Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma (original) (raw)

References

  1. Jaffe ES, Harris NL, Stein H, Vardiman JW (eds). World Health Organization Classification of Tumours. Pathology and Genetics: Tumours of Haemopoietic and Lymphoid Tissues. IARC Press: Lyon, 2001.
    Google Scholar
  2. Lennert K, Feller AC . Histopathology of Non-Hodgkin's Lymphomas (Based on the Updated Kiel Classification), 2nd edn. Springer-Verlag: New York, Berlin, Heidelberg, 1992.
    Book Google Scholar
  3. López-Guillermo A, Cid J, Salar A, López A, Montalbán C, Castrillo JM et al. Peripheral T-cell lymphomas: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification. Ann Oncol 1998; 9: 849–855.
    Article PubMed Google Scholar
  4. Rüdiger T, Weisenburger DD, Anderson JR, Armitage JO, Diebold J, MacLennan KA, et al., for the Non-Hodgkin's Lymphoma Classification Project. Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project. Ann Oncol 2002; 13: 140–149.
    Article PubMed Google Scholar
  5. Anderson JR, Armitage JO, Weisenburger DD . Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project. Ann Oncol 1998; 9: 717–720.
    Article CAS PubMed Google Scholar
  6. Gisselbrecht C, Gaulard P, Lepage E, Coiffier B, Brière J, Haioun C, et al., for the Groupe d'Etudes des Lymphomes de l'Adulte (GELA). Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Blood 1998; 92: 76–82.
    CAS PubMed Google Scholar
  7. Lepretre S, Buchonnet G, Stamatoullas A, Lenain P, Duval C, d'Anjou J et al. Chromosome abnormalities in peripheral T-cell lymphoma. Cancer Genet Cytogenet 2000; 117: 71–79.
    Article CAS PubMed Google Scholar
  8. Renedo M, Martinez-Delgado B, Arranz E, Garcia M, Urioste M, Martinez-Ramirez A et al. Chromosomal changes pattern and gene amplification in T cell non-Hodgkin's lymphomas. Leukemia 2001; 15: 1627–1632.
    Article CAS PubMed Google Scholar
  9. Chen CY, Yao M, Tang JL, Tsay W, Wang CC, Chou WC et al. Chromosomal abnormalities of 200 Chinese patients with non-Hodgkin's lymphoma in Taiwan: with special reference to T-cell lymphoma. Ann Oncol 2004; 15: 1091–1096.
    Article PubMed Google Scholar
  10. Schlegelberger B, Himmler A, Godde E, Grote W, Feller AC, Lennert K . Cytogenetic findings in peripheral T-cell lymphomas as a basis for distinguishing low-grade and high-grade lymphomas. Blood 1994; 83: 505–511.
    CAS PubMed Google Scholar
  11. Schlegelberger B, Himmler A, Bartles H, Kuse R, Sterry W, Grote W . Recurrent chromosome abnormalities in peripheral T-cell lymphomas. Cancer Genet Cytogenet 1994; 78: 15–22.
    Article CAS PubMed Google Scholar
  12. de Leval L, Savilo E, Longtine J, Ferry JA, Harris NL . Peripheral T-cell lymphoma with follicular involvement and a CD4+/bcl-6+ phenotype. Am J Surg Pathol 2001; 25: 395–400.
    Article CAS PubMed Google Scholar
  13. Rüdiger T, Ichinohasama R, Ott MM, Müller-Deubert S, Miura I, Ott G et al. Peripheral T-cell lymphoma with distinct perifollicular growth pattern: a distinct subtype of T-cell lymphoma? Am J Surg Pathol 2000; 24: 117–122.
    Article PubMed Google Scholar
  14. Chott A, Haedicke W, Mosberger I, Födinger M, Winkler K, Mannhalter C et al. Most CD56+ intestinal lymphomas are CD8+CD5− T-cell lymphomas of monomorphic small to medium size histology. Am J Pathol 1998; 153: 1483–1490.
    Article CAS PubMed PubMed Central Google Scholar
  15. Streubel B, Vinatzer U, Lamprecht A, Raderer M, Chott A . T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma. Leukemia 2005; 19: 652–658.
    Article CAS PubMed Google Scholar
  16. Yang W, Collette Y, Nunes JA, Olive D . Tec kinases: a family with multiple roles in immunity. Immunity 2000; 12: 373–382.
    Article CAS PubMed Google Scholar
  17. Lewis CM, Broussard C, Czar MJ, Schwartzberg PL . Tec kinases: modulators of lymphocyte signaling and development. Curr Opin Immunol 2001; 13: 317–325.
    Article CAS PubMed Google Scholar
  18. Andreotti AH, Bunnell SC, Feng S, Berg LJ, Schreiber SL . Regulatory intramolecular association in a tyrosine kinase of the Tec family. Nature 1997; 385: 93–97.
    Article CAS PubMed Google Scholar
  19. Liao XC, Littman DR . Altered T cell receptor signaling and disrupted T cell development in mice lacking Itk. Immunity 1995; 3: 757–769.
    Article CAS PubMed Google Scholar
  20. Schaeffer EM, Debnath J, Yap G, McVicar D, Liao XC, Littman DR et al. Requirement for Tec kinases Rlk and Itk in T cell receptor signaling and immunity. Science 1999; 284: 638–641.
    Article CAS PubMed Google Scholar
  21. Liu K, Bunnell SC, Gurniak CB, Berg LJ . T cell receptor-initiated calcium release is uncoupled from capacitative calcium entry in Itk-deficient T cells. J Exp Med 1998; 187: 1721–1727.
    Article CAS PubMed PubMed Central Google Scholar
  22. Kuno Y, Abe A, Emi N, Iida M, Yokozawa T, Towatari M et al. Constitutive kinase activation of the TEL–Syk fusion gene in myelodysplastic syndrome with t(9;12)(q22;p12). Blood 2001; 97: 1050–1055.
    Article CAS PubMed Google Scholar
  23. Golub TR, Barker GF, Lovett M, Gilliland DG . Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 1994; 77: 307–316.
    Article CAS PubMed Google Scholar
  24. Kanie T, Abe A, Matsuda T, Kuno Y, Towatari M, Yamamoto T et al. TEL-Syk fusion constitutively activates PI3-K/Akt, MAPK and JAK2-independent STAT5 signal pathways. Leukemia 1994; 18: 548–555.
    Article Google Scholar
  25. Czar MJ, Debnath J, Schaeffer EM, Lewis CM, Schwartzberg PL . Biochemical and genetic analyses of the Tec kinases Itk and Rlk/Txk. Biochem Soc Trans 2001; 29: 863–867.
    Article CAS PubMed Google Scholar
  26. Bolen JB, Brugge JS . Leukocyte protein tyrosine kinases: potential targets for drug discovery. Annu Rev Immunol 1997; 15: 371–404.
    Article CAS PubMed Google Scholar
  27. Chan AC, van Oers NSC, Tran A, Turka L, Law CL, Ryan JC et al. Differential expression of ZAP-70 and Syk protein tyrosine kinases, and the role of this family of protein tyrosine kinases in TCR signaling. J Immunol 1994; 152: 4758–4766.
    CAS PubMed Google Scholar
  28. Takada Y, Aggarwal BB . TNF activates Syk protein tyrosine kinase leading to TNF-induced MAPK activation, NF-_κ_B activation, and apoptosis. J Immunol 2004; 173: 1066–1077.
    Article CAS PubMed Google Scholar
  29. Attygalle A, Al-Jehani R, Diss TC, Munson P, Liu H, Du MQ et al. Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10. Blood 2002; 99: 627–633.
    Article CAS PubMed Google Scholar

Download references